Influence of c-myc on the progression of human breast cancer

Current Topics in Microbiology and Immunology

Volumn 213 II, Issue , 1996, Pages 267-283

  Watson, P H ^a   Singh, R ^a   Hole, A K ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER INVASION; CELL ADHESION; CELL LINE; GENE EXPRESSION REGULATION; HUMAN; METASTASIS; ONCOGENE C MYC; PRIORITY JOURNAL; REVIEW;

EID: 0029940979     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-61109-4_13     Document Type: Review

References (147)

1. Adnane J, Gaudray P, Simon MP, Simony Lafontaine J, Jeanteur P, Theillet C (1989) Protooncogene amplification and human breast tumor phenotype. Oncogene 4: 1389-1395
2. Aghib DF, Bishop JM (1991) A 3′ truncation of myc caused by chromosomal translocation in a human Tcell leukemia is tumorigenic when tested in established rat fibroblasts. Oncogene 6. 2371-2375
3. Aghib DF, Bishop JM, Ottolenghi S, Guerrasio A, Serra A, Saglio G (1990) A 3′ truncation of MYC caused by chromosomal translocation in a human Tcell leukemia increases mRNA stability. Oncogene 5: 707-711
4. Akeson R, Bernards R (1990) N-myc down regulates neural cell adhesion molecule expession in rat neuroblastoma. Mol Cell Biol 10: 2012-2016
5. Ali IU, Lidereau R, Callahan R (1989) Presence of two members of c-erbA receptor gene family (c-erbA beta and c-erbA2) in smallest region of somatic homozygosity on chromosome 3p21-p25 in human breast carcinoma J Natl Cancer Inst 81: 1815-1820
6. Behrens J, Lowrick O, Klein Hitpass L, Birchmeier W (1991) The E-cadherin promoter. functional analysis of a G. C-rich region and an epithelial cell-specific palindromic regulatory element. Proc Natl Acad Sci USA 88: 11495-11499
7. Bello Fernandez C, Packham G, Cleveland JL (1993) The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc Natl Acad Sci USA 90: 7804-7808
8. Benvensity N, Leder A, Kuo A, Leder P (1992) An embryonically expressed gene is a target for c-Myc regulation via the c-Myc binding sequence. Genes Dev 6: 2513-2523
9. Bernards R, Dessain SK, Weinberg RA (1986) N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma. Cell 47: 667-674
10. Berns EM, Klijn JG, van Putten WL, van Staveren IL, Portengen H, Foekens JA (1992a) c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer Cancer Res 52. 1107-1113
11. Berns EM, Klijn JG, van Staveren IL, Portengen H, Noordegraaf E, Foekens JA (1992b) Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors Eur J Cancer 28: 697-700
12. Berns EM, Klijn JG, Look MP, van Staveren IL, Portengen H, Foekens JA (1995) separate oncogene amplification for prediction of recurrent breast cancer: an analysis on 662 patients Proc Am Assoc Cancer Res 36: 558 (abstr)
13. Bieche I, Champeme MH, Matifas F, Hacene K, Callahan R, Lidereau R (1992) Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer Lancet 339: 139-143
14. Bieche I, Champeme MH, Lidereau R (1994) A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer. Cancer Res 54: 4274-4276
15. Blackwood EM, Eisenman RN (1991) Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251. 1211-1217
16. Bolufer P, Molina R, Ruiz A, Hernandez M, Vazquez C, Lluch A (1994) Estradiol receptors in combination with neu or myc oncogene amplifications might define new subtypes of breast cancer. Clin Chim Acta 229. 107-122
17. Borg A, Baldetorp B, Ferno M, Olsson H, Sigurdsson H (1992) c-myc amplification is an independent prognostic factor in postmenopausal breast cancer Int J Cancer 51: 687-691
18. Bos JL (1989) ras oncogenes in human cancer a review. Cancer Res 49. 4682-4689
19. Bradley MO, Kraynak AR, Storer RD, Gibbs JB (1986) Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes. Proc Natl Acad Sci USA 83: 5277-5281
20. Brouillet JP, Theillet C, Maudelonde T, Defrenne A, Simony Lafontaine J, Sertour J, Pujol H, Jeanteur P, Rochefort H (1990) Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness. Eur J Cancer 26: 437-441
21. Callahan R (1992) p53 mutations, another breast cancer prognostic factor. J Natl Cancer Inst 84: 826-827
22. Castronovo V, Taraboletti G, Liotta LA, Sobel ME (1989) Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines. J Natl Cancer Inst 81 781-788
23. Clarke R, Thompson EW, Leonessa F, Lippman J, McGarvey M, Frandsen TL, Brunner N (1993) Hormone resistance, invasiveness, and metastatic potential in breast cancer. Breast Cancer Res Treat 24: 227-239
24. Daksis JI, Lu RY, Facchini LM, Marhin WW, Penn LJ (1994) Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle Oncogene 9. 3635-3645
25. Dang CV (1991) c-myc oncoprotein function. Biochim Biophys Acta 1072: 103-113
26. Devilee P, Cornelisse CJ (1990) Genetics of human breast cancer. Cancer Surv 9. 605-630
27. Dhawan J, Farmer SR (1990) Regulation of alpha 1 (I)-collagen gene expression in response to cell adhesion in Swiss 3T3 fibroblasts. J Biol Chem 265: 9015-9021
28. Dickinson Laing TMA, Gibson AW, Johnson RN, Edwards DR (1995) Role of c-myc in regulation of gelatinase B expression. Proc Am Assoc Cancer Res 36: 97 (abstr)
29. Dickson RB, Lippman ME (1987) Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocri Inol Rev 8: 29-43
30. Dickson RB, Lippman ME (1992) Molecular determinants of growth, angiogenesis, and metastases in breast cancer. Semin Oncol 19: 286-298
31. Dubik D, Dembinski TC, Shiu RP (1987) Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells Cancer Res 47: 6517-6521
32. Dubik D, Shiu RP (1988) Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells J Biol Chem 263: 12705-12708
33. Dubik D, Shiu RP (1992) Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7: 1587-1594
34. Duffy MJ (1992) The role of proteolytic enzymes in cancer invasion and metastasis Clin Exp Metastasis 10: 145-155
35. Egan SE, Wright JA, Jarolim L, Yanagihara k, Bassin RH, Greenberg AH (1987) Transformation by oncogenes encoding protein kinases induces the metastatic phenotype. Science 238. 202-205
36. Egan SE, Wright JA, Greenberg AH (1991) Molecular determinants of metastatic transformation. Environ Health Perspect 93. 91-95
37. Eilers M, Schirm S, Bishop JM (1991) The MYC protein activates transcription of the alpha-prothymosin gene EMBO J 10: 133-141
38. Erisman MD, Rothberg PG, Diehl RE, Morse CC, Spandorfer JM, Astrin SM. (1985) Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene Mol Cell Biol 5: 1969-1976
39. Escot C, Theillet C, Lidereau R, Spyratos F, Champeme MH, Gest J, Callahan R (1986) Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas. Proc Natl Acad Sci USA 83 4834-4838
40. Escot C, Simony Lafontaine J, Maudelonde T, Puech C, Pujol H, Rochefort H (1993) Potential value of increased MYC but not ERBB2 RNA levels as a marker of high-risk mastopathies [published erratum appears in Oncogene (7). 2023]. Oncogene 8: 969-974
41. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC (1992) Induction of apoptosis in fibroblasts by c-myc protein Cell 69: 119-128
42. Facchini LF, Chen S, Penn LJZ (1995) Myc repression of gene transcription: one pathway or many? Proc Am Assoc Cancer Res 36. 532 (abstr)
43. Fisher B (1992) The evolution of paradigms for the management of breast cancer: a personal perspective Cancer Res 52: 2371-2383
44. Foekens JA, Schmitt M, Van Putten WL, Peters HA, Kramer MD, Janicke F, Klijn JG (1994) Plasminogen activator inhibitor-1 and prognosis in primary breast cancer. J Clin Oncol 12: 1648-1658
45. Foulds LJ (1958) The natural history of cancer. J Chronic Disease 8: 2-37
46. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, Birchmeier W (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185
47. Gaffey MJ, Frierson HF Jr, Williams ME (1993) Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations Mod Pathol 6. 654-659
48. Garcia I, Dietrich PY, Aapro M, Vauthier G, Vadas L, Engel E (1989) Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas. Cancer Res 49: 6675-6679
49. Gaubatz S, Meichle A, Eilers M (1994) An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc. Mol Cell Biol 14. 3853-3862
50. Gelmann EP, Thompson EW, Sommers CL (1992) Invasive and metastatic properties of MCF-7 cells and rasH-transfected MCF-7 cell lines. Int J Cancer 50: 665-669
51. Gross N, Beretta C, Peruisseau G, Jackson D, Simmons D, Beck D (1994) CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation. Cancer Res 54: 4238-4242
52. Guerin M, Barrois M, Terrier MJ, Spielmann M, Riou G (1988) Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis. Oncogene Res 3: 21-31
53. Halazonetis TD, Kandil AN (1991) Determination of the c-MYC DNA-binding site Proc Natl Acad Sci USA 88: 6162-6166
54. Hann SR, Eisenman RN (1984) Proteins encoded by the human c-myc oncogene differential expression in neoplastic cells. Mol Cell Biol 4: 2486-2497
55. Harada Y, Katagiri T, Ito I, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y, Emi M (1994) Genetic studies of 457 breast cancers Clinicopathologic parameters compared with genetic alterations Cancer 74: 2281-2286
56. Hehir DJ, McGreal G, Kirwan WO, Kealy W, Brady MP (1993) C-myc oncogene expression: a marker for females at risk of breast carcinoma J Surg Oncol 54. 207-209
57. Heikkila R, Schwab G, Wickstrom E, Loke SL, Pluznik DH, Watt R, Neckers LM (1987) A C-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from GO to G1 Nature 328: 445-449
58. Hennessy C, Henry JA, May FE, Westley BR, Angus B, Lennard TW (1991) Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis J Natl Cancer Inst 83: 281-285
59. Henry JA, Hennessy C, Levett DL, Lennard TW, Westley BR, May FE (1993) int-2 amplification in breast cancer, association with decreased survival and realationship to amplification of c-erbB-2 and c-myc Int J Cancer 53: 774-780
60. Howlett AR, Petersen OW, Steeg PS, Bissell MJ (1994) A novel function for the nm23-H1 gene. overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. J Natl Cancer Inst 86: 1838-1844
61. Inghirami G, Grignani F, Sternas L, Lombardi L, Knowles DM, Dalla Favera R (1990) Down-regulation of LFA-1 adhesion receptors by C-myc oncogene in human B lymphoblastoid cells. Science 250: 682-686
62. Isola J, DeVries S, Chu L, Ghazvini S, Waldman F (1994) Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples Am J Pathol 145: 1301-1308
63. Jansen Durr P, Meichle A, Steiner P, Pagano M, Finke K, Botz J, Wessbecher J, Draetta G, Eilers M (1993) Differential modulation of cyclin gene expression by MYC. Proc Natl Acad Sci USA 90: 3685-3689
64. Jones TR, Cote MD (1987) Rapid cytoplasmic turnover of c-myc mRNA: requirement of the 3′untranslated sequences. Mol Cell Biol 7 4513-4521
65. Kallioniemi OP, Kallioniemi A, Kurisu W, Thor A, Chen LC, Smith HS, Waldman FM, Pinkel D, Gray JW (1992) ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci USA 89: 5321-5325
66. Karp JE, Broder S (1991) Acquired immunodeficiency syndrome and non-Hodgkins' lymphomas. Cancer Res 51: 4743-4756
67. Kerbel RS (1989) Towards an understanding of the molecular basis of the metastatic phenotype. Invasion Metastasis 9: 329-337
68. Klein G, Klein E (1986) Conditioned tumorigenicity of activated oncogenes Cancer Res 46: 3211-3224
69. Knyazev PG, Imyanitov EN, Chernitsa OI, Nikiforova IF (1993) Loss of heterozygosity at chromosome 17p is associated with HER-2 amplification and lack of nodal involvement in breast cancer. Int J Cancer 53: 11-16
70. Kreipe H, Feist H, Fischer L, Felgner J, Heidorn K, Mettler L, Parwaresch R (1993) Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer Cancer Res 53: 1956-1961
71. LeRoy X, Escot C, Brouillet JP, Theillet C, Maudelonde T, Simony Lafontaine J, Pujol H, Rochefort H (1991) Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer. Oncogene 6: 431-437
72. Leder A, Pattengale PK, Kuo A, Stewart TA, Leder P (1986) Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell 45: 485-495
73. Leone A, Flatow U, VanHoutte K, Steeg PS (1993) Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene 8: 2325-2333
74. Li LH, Nerlov C, Prendergast G, MacGregor D, Ziff EB (1994) c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J 13: 4070-4079
75. Liotta LA (1988) Growth autonomy: the only requirement for metastasis? J Natl Cancer Inst 80: 300
76. Liotta LA, Stetler Stevenson WG (1991) Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51: 5054s-5059s
77. Little CD, Nau MM, Carney DN, Gazdar AF, Minna JD (1983) Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 306: 194-196
78. Luscher B, Eisenman RN (1990) New light on Myc and Myb I. Myc Genes Dev 4: 2025-2035
79. Luscher B, Eisenman RN (1992) Mitosis-specific phosphorylation of the nuclear oncoproteins Myc and Myb. J Cell Biol 118. 775-784
80. Luscher B, Kuenzel EA, Krebs EG, Eisenman RN (1989) Myc oncoproteins are phosphorylated by casein kinase II. EMBO J 8. 1111-1119
81. Machotka SV, Garrett CT, Schwartz AM, Callahan R (1989) Amplification of the proto-oncogenes int-2, c-erb B-2 and c-myc in human breast cancer. Clin Chim Acta 184: 207-217
82. Mai S, Jalava A (1994) c-Myc binds 5′flanking sequence motifs of the dihydrofolate reductase gene in cellular extracts: role in proliferation Nucleic Acids Res 22. 2264-2273
83. Mareel MM, Van Roy FM, De Baetselier P (1990) The invasive phenotypes. Cancer Metastasis Rev 9: 45-62
84. Mariani Costantini R, Escot C, Theillet C, Gentile A, Merlo G, Lidereau R, Callahan R (1988) In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast. Cancer Res 48: 199-205
85. McGuire WL (1987) Prognostic factors for recurrence and survival in human breast cancer. Breast Cancer Res Treat 10: 5-9
86. McGuire WL, Clark GM (1992) Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl J Med 326. 1756-1761
87. McGuire WL, Chamness GC, Fuqua SA (1991) Estrogen receptor variants in clinical breast cancer. Mol Endocrinol 5: 1571-1577
88. Meyers SL, O'Brien MT, Smith T, Dudley JP (1990) Analysis of the int-1, int-2, c-myc, and neuoncogenes in human breast carcinomas. Cancer Res 50: 5911-5918
89. Miller TL, Huzel NJ, Davie JR, Murphy LC (1993) C-myc gene chromatin of estrogen receptor positive and negative breast cancer cells. Mol Cell Endocrinol 91 83-89
90. Millon R, Nicora F, Muller D, Eber M, Klein Soyer C, Abecassis J (1989) Modulation of human breast cancer cell adhesion by estrogens and antiestrogens. Clin Exp Metastasis 7. 405-415
91. Murphy LC (1990) Estrogen receptor variants in human breast cancer. Mol Cell Endocrinol 74: C83-6
92. Musgrove EA, Hamilton JA, Lee CS, Sweeney KJ, Watts CK, Sutherland RL (1993) Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol Cell Biol 13: 3577-3587
93. Ochieng J, Basolo F, Albini A, Melchiori A, Watanabe H, Elliott J, Raz A, Parodi S, Russo J (1991) Increased invasive, chemotactic and locomotive abilities of c-Ha-ras-transformed human breast epithelial cells Invasion Metastasis 11: 38-47
94. Ottestad L, Andersen TI, Nesland JM, Skrede M, Tveit KM, Nustad K, Borresen AL (1993) Amplification of c-erbB-2, int-2 and c-myc genes in node-negative breast carcinomas. Relationship to prognosis. Acta Oncol 32: 289-294
95. Paterson MC, Dietrich KD, Danyluk J, Paterson AH, Lees AW, Jamil N, Hanson J, Jenkins H, Krause BE, McBlain WA et al. (1991) Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. Cancer Res 51: 556-567
96. Pavelic ZP, Pavelic K, Carter CP, Pavelic L (1992) Heterogeneity of c-myc expression in histologically similar infiltrating ductal carcinomas of the breast. J Cancer Res Clin Oncol 118. 16-22
97. Peltenburg LT, Schrier PI (1994) Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements. Immunogenetics 40: 54-61
98. Peltenburg LT, Dee R, Schrier PI (1993) Downregulation of HLA class I expression by c-myc in human melanoma is independent of enhancer A Nucleic Acids Res 21: 1179-1185
99. Pena A, Reddy CD, Wu S, Hickok NJ, Reddy EP, Yumet G, Soprano DR, Soprano KJ (1993) Regulation of human ornithine decarboxylase expression by the c-Myc. Max protein complex. J Biol Chem 268: 27277-27285
100. Penn LJ, Brooks MW, Laufer EM, Land H (1990a) Negative autoregulation of c-myc transcription. EMBO J 9: 1113-1121
101. Penn LJ, Brooks MW, Laufer EM, Littlewood TD, Morgenstern JP, Evan GI, Lee WM, Land H (1990b) Domains of human c-myc protein required for autosuppression and cooperation with ras oncogenes are overlapping. Mol Cell Biol 10: 4961-4966
102. Philip A, schneider A, Vasrik I, Finke K, Xiong Y, Beach D, Alitalo K, Eilers M (1994) Repression of cyclin D1. a novel function of MYC. Mol Cell Biol 14: 4032-4043
103. Postel EH, Berberich SJ, Flint SJ, Ferrone CA (1993) Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science 261: 478-480
104. Prendergast GC, Cole MD (1989) Posttranscriptional regulation of cellular gene expression by the c-myc oncogene. Mol Cell Biol 9, 124-134
105. Prendergast GC, Diamond LE, Dahl D, Cole MD (1990) The c-myc-regulated gene mr1 encodes plasminogen activatorr inhibitor 1. Mol Cell Biol 10: 1265-1269
106. Reisman D, Elkind NB, Roy B, Beamon J, Rotter V (1993) c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif Cell Growth Differ 4: 57-65
107. Rochefort H (1992) Cathepsin D in breast cancer: a tissue marker associated with metastasis. Eur J Cancer 28A. 1780-1783
108. Roux Dosseto M, Romain S, Dussault N, Desideri C, Piana L, Bonnier P, Tubiana N, Martin PM (1992) c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapse. Eur J Cancer 28A: 1600-1604
109. Royds JA, Stephenson TJ, Rees RC, Shorthouse AJ, Silcocks PB (1993) Nm23 protein expression in ductal in situ and invasive human breast carcinoma J Natl Cancer Inst 85: 727-731
110. Sawan A, Lascu I, Veron M, Anderson JJ, Wright C, Horne CH, Angus B (1994) NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and opther prognostic factors. an immunohistochemical study J Pathol 172. 27-34
111. Scarpa A, Borgato L, Chilosi M, Capelli P, Menestrina F, Bonetti F, Zamboni G, Pizzolo G, Hirohashi S, Fiore Donati L (1991) Evidence of c-myc gene abnormalities in mediastinal large B-cell lymphoma of young adult age. Blood 78: 780-788
112. Schoenenberger CA, Andres AC, Groner B, van der Valk M, LeMeur M, Gerlinger P (1988) Targeted c-myc gene expression in mammary glands of transgenic mice induces mammary tumors with constitutive milk protein gene transcription EMBO J 7: 169-175
113. Scorilas A, Yotis J, Gouriotis D, Keramopoulos A, Ampela K, Trangas T, Talieri M (1993) Cathepsin-D and c-erb-B2 have an additive prognostic value for breast cancer patients. Anticancer Res 13 1895-1900
114. Seshadri R, Mathews C, Dobrovic A, Horsfall DJ (1989) The significance of oncogene amplification in primary breast cancer. Int J Cancer 43: 270-272
115. Shapiro DN, Valentine MB, Rowe ST, Sinclair AE, Sublett JE, Roberts WM, Look AT (1993) Detection of N-myc gene amplification by fluorescence in situ hybridization. Diagnostic utility for neuroblastoma Am J Pathol 142: 1339-1346
116. Sheikh MS, Shao ZM, Chen JC, Ordonez JV, Fontana JA (1993) Retinoid modulation of c-myc and max gene expression in human breast carcinoma. Anticancer Res 13: 1387-1392
117. Shi YE, Torri J, Yieh L, Sobel ME, Yamada Y, Lippman ME, Dickson RB, Thompson EW (1993) Expression of 67kDa laminin receptor in human breast cancer cells regulation by progestins. Clin Exp Metastasis 11. 251-261
118. Shtivelman E, Bishop JM (1991) Expression of CD44 is represented in neuroblastoma cells. Mol Cell Biol 11: 5446-5452
119. Simpson JF, Page DL (1992) Prognostic value of histopathology in the breast. Semin Oncol 19. 254-262
120. Soini Y, Mannermaa A, Winqvist R, Kamel D, Poikonen K, Kiviniemi H, Paakko P (1994) Application of fine-needle aspiration to the demonstration of ERBB2 and MYC expression by in situ hybridization in breast carcinoma J Histochem Cytochem 42. 795-803
121. Spandidos DA, Yiagnisis M, Papadimitriou K, Field JK (1989) ras, c-myc and c-erbB-2 oncoproteins in human breast cancer. Anticancer Res 9: 1385-1393
122. Spencer CA, Groudine M (1990) Transcription elongation and eukaryotic gene regulation. Oncogene 5: 777-785
123. Steeg PS, De la Rosa A, Flatow U, MacDonald NJ, Benedict M, Leone A (1993) Nm23 and breast cancer metastasis. Breast Cancer Res Treat 25. 175-187
124. Studzinski GP, Brelvi ZS, Feldman SC, Watt RA (1986) Participation of c-myc protein in DNA synthesis of human cells. Science 234: 467-470
125. Suen TC, Hung MC (1991) c-myc reverses neu-induced transformed morphology by transcriptional repression. Mol Cell Biol 11: 354-362
126. Tandon AK, Clark GM, Chamness GC, Chirgwin JM, McGuire WL (1990) Cathepsin D and prognosis in breast cancer. N Engl J Med 322: 297-302
127. Tang RP, Kacinski B, Validire P, Beuvon F, Sastre X, Benoit P, dela Rochefordiere A, Mosseri V, Pouillart P, Scholl S (1990) Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: a role for hematopoietic growth factor release by tumor cells? J Cell Biochem 44: 189-198
128. Tavassoli M, Quirke P, Farzaneh F, Lock NJ, Mayne LV, Kirkham N (1989) c-erbB-2/c-erbA coamplification indicative of lymph node metastasis and c-myc amplification of high tumor grade, in human breast carcinoma Br J Cancer 60: 505-510
129. Thompson EW, Katz D, Shima TB, Wakeling AE, Lippman ME, Dickson RB (1989) ICI 164, 384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness Cancer Res 49. 6929-6934
130. Thompson EW, Lippman ME, Dickson RB (1991) Regulation of basement membrane invasiveness in human breast cancer model systems Mol Cell Endocrinol 82. C203-8
131. Thompson EW, Paik S, Brunner N, Sommers CL, Zugmaier G, Clarke R, Shima TB, Torri J, Donahue S, Lippman ME et al (1992) Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 150 534-544
132. Thompson EW, Torri J, Sabol M, Sommers CL, Byers S, Valverius EM, Martin GR, Lippman ME, Stampfer MR, Dickson RB (1994) Oncogene-induced basement membrane invasiveness in human mammary epithelial cells. Clin Exp Metastasis 12: 181-194
133. Tsuda H, Hirohashi S, Shimosato Y, Hirota T, Tsugane S, Yamamoto H, Miyajima N, Toyoshima K, Yamamoto T, Yokota J et al. (1989) Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units hst-1/int-2 and c-erbB-2/ear-1. Cancer Res 49: 3104-3108
134. Tsuda H, Hirohashi S, Hirota T, Shimosato Y (1991) Alterations in copy number of c-erbB-2 and c-myc proto-oncogenes in advanced stage of human breast cancer. Acta Pathol Jpn 41: 19-23
135. van den Brule FA, Engel J, Stetler-Stevenson WG, Liu FT, Sobel ME, Castronovo V (1992) Genes involved in tumor invasion and metastasis are differently modulated by estradiol and progestin in human breast-cancer cells. Int J Cancer 52 653-657
136. Varley JM, Swallow JE, Brammar WJ, Whittaker JL, Walker RA (1987a) Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis. Oncogene 1: 423-430
137. Varley JM, Wainwright AM, Brammar WJ (1987b) An unusual alteration in c-myc in tissue from a primary breast carcinoma Oncogene 1: 431-438
138. Versteeg R, Noordermeer IA, Kruse Wolters M, Ruiter DJ, Schrier PI (1988) c-myc down-regulates class I HLA expression in human melanomas. EMBO J 7: 1023-1029
139. Walker RA, Senior PV, Jones JL, Critchley DR, Varley JM (1989) An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas. J Pathol 158: 97-105
140. Wasfy G, Marhin W, Lu R, Daksis J, Penn LJZ (1995) Cloning and identification of myc regulated genes. Proc Am Assoc Cancer Res 36: 521 (abstr)
141. Watson PH, Baral E (1991) Endocrine therapy of breast cancer: research trailing the clinical edge Can J Oncol 1 42-44
142. Watson PH, Pon RT, Shiu RP (1991) Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer Cancer Res 51. 3996-4000
143. Watson PH, Safneck JR, Le K, Dubik D, Shiu RP (1993) Relationship of c-myc amplification to progression or breast cancer from in situ to invasive tumor and lymph node metastasis. J Natl Cancer Inst 85: 902-907
144. Watson PH, Snell L, Millns AK (1994) CD44 expression and estrogen receptor status in human breast cancer. American Association for Cancer Research Conference on Molecules Genetics of Tumor Progression, February 1994, Big Sky, Montana, Abstr no A-30
145. Yang BS, Geddes TJ, Pogulis RJ, de Crombrugghe B, Freytag SO (1991) Transcriptional suppression of cellular gene expression by c-myc. Mol Cell Biol 11: 2291-2295
146. Zajac Kaye M, Gelmann EP, Levens D (1988) A point mutation in the c-myc locus of a Burkitt lymphoma abolishes binding of a nuclear protein Science 240 1776-1780
147. Zhou DJ, Ahuja H, Cline MJ (1989) Proto-oncogene abnormalities in human breast cancer. c-ERBB-2 amplification does not correlate with recurrence of disease. Oncogene 4: 105-108